Cargando…
Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis
Autoimmune hepatitis (AIH) is an immune‐mediated liver disease currently treated by immunosuppressive medications with significant side effects. Thus, novel mechanistic treatments are greatly needed. We performed prospective deep immunophenotyping of blood immune cells in patients with acute AIH bef...
Autores principales: | Jeffery, Hannah C., Braitch, Manjit K., Bagnall, Chris, Hodson, James, Jeffery, Louisa E., Wawman, Rebecca E., Wong, Lin Lee, Birtwistle, Jane, Bartlett, Helen, Lohse, Ansgar W., Hirschfield, Gideon M., Dyson, Jessica, Jones, David, Hubscher, Stefan G., Klenerman, Paul, Adams, David H., Oo, Ye H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880196/ https://www.ncbi.nlm.nih.gov/pubmed/29619420 http://dx.doi.org/10.1002/hep4.1163 |
Ejemplares similares
-
Human intrahepatic ILC2 are IL-13(positive )amphiregulin(positive) and their frequency correlates with model of end stage liver disease score
por: Jeffery, Hannah C., et al.
Publicado: (2017) -
Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives
por: Jeffery, Hannah C., et al.
Publicado: (2016) -
Human intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosis
por: Chen, Yung‐Yi, et al.
Publicado: (2016) -
Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis
por: Oo, Ye Htun, et al.
Publicado: (2019) -
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom
por: Dyson, Jessica K., et al.
Publicado: (2018)